Hospitals | April 04, 2026
Apollo Hospitals hosts specialist dialogue on vertigo diagnosis challenges
Hands-on clinical workshop in Bengaluru brings together neurologists, ENT specialists and physicians
Hands-on clinical workshop in Bengaluru brings together neurologists, ENT specialists and physicians
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume
The open-label trial involved 105 adults with schizophrenia who were on a stable dose of an oral atypical antipsychotic for at least six weeks
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
The company plans to submit the vaccine for regulatory review
The global, first-in-human, open-label trial will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of TRI-611
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
Subscribe To Our Newsletter & Stay Updated
